Insufficient scRNA-seq data for expression of BFSP2 at single-cell level.
Insufficient scRNA-seq data for expression of BFSP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 86% | 13.27 | 561 / 653 | 17% | 0.49 | 101 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.76 | 29 / 29 |
spleen | 100% | 73.97 | 241 / 241 | 0% | 0 | 0 / 0 |
kidney | 89% | 8.99 | 79 / 89 | 6% | 0.16 | 53 / 901 |
breast | 60% | 18.93 | 277 / 459 | 19% | 0.62 | 211 / 1118 |
peripheral blood | 79% | 79.36 | 732 / 929 | 0% | 0 | 0 / 0 |
skin | 49% | 2.41 | 893 / 1809 | 28% | 1.57 | 132 / 472 |
stomach | 66% | 6.62 | 237 / 359 | 5% | 0.23 | 13 / 286 |
lung | 57% | 2.76 | 331 / 578 | 11% | 0.24 | 132 / 1155 |
intestine | 56% | 12.08 | 538 / 966 | 4% | 0.11 | 21 / 527 |
bladder | 48% | 1.81 | 10 / 21 | 3% | 0.16 | 17 / 504 |
liver | 27% | 0.80 | 61 / 226 | 10% | 0.25 | 40 / 406 |
brain | 36% | 1.21 | 955 / 2642 | 1% | 0.04 | 4 / 705 |
esophagus | 31% | 1.13 | 441 / 1445 | 3% | 0.05 | 6 / 183 |
prostate | 29% | 1.26 | 71 / 245 | 1% | 0.02 | 5 / 502 |
adipose | 27% | 0.92 | 322 / 1204 | 0% | 0 | 0 / 0 |
heart | 26% | 0.74 | 224 / 861 | 0% | 0 | 0 / 0 |
ovary | 16% | 0.41 | 29 / 180 | 5% | 0.11 | 23 / 430 |
uterus | 17% | 0.55 | 29 / 170 | 4% | 0.07 | 19 / 459 |
adrenal gland | 19% | 0.59 | 50 / 258 | 1% | 0.04 | 2 / 230 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.31 | 9 / 45 |
pancreas | 13% | 0.35 | 42 / 328 | 5% | 0.20 | 9 / 178 |
blood vessel | 12% | 0.45 | 157 / 1335 | 0% | 0 | 0 / 0 |
muscle | 8% | 0.22 | 64 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.42 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0045109 | Biological process | intermediate filament organization |
GO_0048469 | Biological process | cell maturation |
GO_0070307 | Biological process | lens fiber cell development |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005882 | Cellular component | intermediate filament |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
Gene name | BFSP2 |
Protein name | Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47) (CP47) (Lens fiber cell beaded filament protein CP 49) (CP49) (Lens intermediate filament-like light) (LIFL-L) |
Synonyms | |
Description | FUNCTION: Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA . Plays a role in maintenance of retinal lens optical clarity (By similarity). . |
Accessions | Q13515 ENST00000302334.3 |